India vs Mus: New or unknown treatment: Pulmonary, bacteriologically confirmed
India
1.01 million
in 2023
Mus
99
in 2023
India rank
1st
Mus rank
1st
New or unknown treatment: Pulmonary, bacteriologically confirmed over time
- India
- Mus
How they compare
India currently reports 1.01 million against 99 in Mus, a difference of 1.01 million.
Across all 11 years both countries report, India has been ahead every year.
India ranks 1st and Mus ranks 1st of 197 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | India | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 783,287 | 113.57 | 783,173 | India |
| 2020s | 866,264 | 94.5 | 866,170 | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, India or Mus?
- India, at 1.01 million against 99 in Mus as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between India and Mus?
- 1.01 million, with India ahead.
- How many years of comparable data are there for India and Mus?
- 11 years are reported by both, from 2013 to 2023.
- How do India and Mus rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- India ranks 1st and Mus ranks 1st of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.